Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer.

Protein advanced glycation end products (AGE) formed by nonenzymatic glycation can disrupt the normal structure and function of proteins, and stimulate the receptor for AGEs (RAGE), triggering intricate mechanisms that are etiologically related to various chronic diseases, including pancreatic cancer. Many common risk factors of pancreatic cancer are the major sources for the formation of protein AGEs and glycative stress in the human body. Abnormal accumulation of protein AGEs can impair the cellular proteome and promote AGE-RAGE driven pro-inflammatory signaling cascades, leading to increased oxidative stress, protease resistance, protein dysregulation, transcription activity of STAT, NF-κB, and AP-1, aberrant status in ubiquitin-proteasome system and autophagy, as well as other molecular events that are susceptible for the carcinogenic transformation towards the development of neoplasms. Here, we review studies to highlight our understanding in the orchestrated molecular events in bridging the impaired proteome, dysregulated functional networks, and cancer hallmarks initiated upon protein AGE formation and accumulation in pancreatic cancer. ©2023 American Association for Cancer Research.

Citation

Lakmini Senavirathna, Sheng Pan, Ru Chen. Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer. Cancer prevention research (Philadelphia, Pa.). 2023 Nov 01;16(11):601-610

Mesh Tags

Substances

PMID: 37578815

search → result